Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,262 public trials 443 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)

NCT02422797

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Washington D.C., District of Columbia, United States
  • GSK Investigational Site Washington D.C., District of Columbia, United States
  • GSK Investigational Site Fort Lauderdale, Florida, United States
View all 61 locations
View Trial Details
Completed

Program Refinements to Optimize Model Impact and Scalability Based on Evidence

NCT03628287

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • HHC Kings County Hospital Center Brooklyn, New York, United States
  • SUNY Downstate Medical Center - STAR Health Center Brooklyn, New York, United States
  • Sunset Park Health Council, Inc. Brooklyn, New York, United States
  • Wyckoff Heights Medical Center Brooklyn, New York, United States
View all 17 locations
View Trial Details
Completed

A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers

NCT04535037

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +19 more
Locations
  • GSK Investigational Site Rosenheim, Bavaria, Germany
  • GSK Investigational Site Schönau am Königssee, Bavaria, Germany
  • GSK Investigational Site Leipzig, Brandenburg, Germany
  • GSK Investigational Site Wolfsburg, Lower Saxony, Germany
View all 20 locations
View Trial Details

Related conditions